Discover
CMND
Clearmind Medicine Inc.
6.22
2 x 4.55
1 x 5.87
bid
ask
+
0.37
6.31%
2 @ 04:00 PM
6.25 +0.03 (0.50%)
| Ytd | -95.71% | |
| 1y | -99.79% |
5.83
day range
6.50
5.25
52 week range
2688.00
| Open | 5.83 | Prev Close | 5.85 | Low | 5.83 | High | 6.50 | Mkt Cap | 3.16M |
| Vol | 10.40K | Avg Vol | 58.53K | EPS | -461.20 | P/E | N/A | Forward P/E | N/A |
| Beta | -1.51 | Short Ratio | 1.88 | Inst. Own | 16.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 8.24 | 200-d Avg | 48.86 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 2.18M | ||
| Research and Development Expense | 588.96K | ||
| Selling, General and Administrative Expense | 1.59M | ||
| Operating Income | -2.18M | ||
| Income Tax Expense | 3.23K | ||
| Net Income | -907.29K | ||
| Net Income Common Stock | -907.29K | ||
| Net Income Common Stock (USD) | -907.29K | ||
| Consolidated Income | -907.29K | ||
| Earnings per Basic Share | -4.56 | ||
| Earnings per Basic Share (USD) | -4.56 | ||
| Earnings per Diluted Share | -4.56 | ||
| Earning Before Interest & Taxes (EBIT) | -904.06K | ||
| Earning Before Interest & Taxes (USD) | -904.06K | ||
| Weighted Average Shares | 197.77K | ||
| Weighted Average Shares Diluted | 197.77K | ||
| Balance Sheet | |||
| Cash and Equivalents | 12.04M | ||
| Cash and Equivalents (USD) | 12.04M | ||
| Investments | 3.91M | ||
| Investments Current | 3.89M | ||
| Investments Non-Current | 20.55K | ||
| Trade and Non-Trade Receivables | 153.13K | ||
| Current Assets | 16.63M | ||
| Property, Plant & Equipment Net | 175.22K | ||
| Total Assets | 16.91M | ||
| Debt Current | 1.70M | ||
| Total Debt | 1.80M | ||
| Current Liabilities | 3.86M | ||
| Debt Non-Current | 101.92K | ||
| Total Liabilities | 3.96M | ||
| Accumulated Retained Earnings (Deficit) | -34.69M | ||
| Accumulated Other Comprehensive Income | -21.25K | ||
| Shareholders Equity | 12.95M | ||
| Shareholders Equity (USD) | 12.95M | ||
| Assets Non-Current | 284.95K | ||
| Total Debt (USD) | 1.80M | ||
| Goodwill and Intangible Assets | 89.18K | ||
| Liabilities Non-Current | 101.92K | ||
| Trade and Non-Trade Payables | 718.78K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 14.22K | ||
| Net Cash Flow from Financing | 3.34M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 619.49K | ||
| Issuance (Purchase) of Equity Shares | 18.15K | ||
| Issuance (Repayment) of Debt Securities | 3.32M | ||
| Net Cash Flow from Investing | -778.16K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -778.16K | ||
| Net Cash Flow from Operations | -1.93M | ||
| Effect of Exchange Rate Changes on Cash | -7.34K | ||
| Share Based Compensation | 131.25K | ||